This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Retirement planning involves several important steps. Discover the key actions you need to take to secure your financial future.
17,708 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Nvidia has built an AI powerhouse, but its stock sits at a valuation that invites scrutiny. This guide breaks down wh...
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
H&R Block’s Q3 results set the tone for block (hrb) 2026 earnings. This guide breaks down the numbers, strategy, and ...
Opal Fuels is on investors’ radar for 2026. This guide breaks down the earnings landscape, core drivers, and how to e...
Investors are watching Bullish (BLSH) as Q1 2026 results set the tone for the year. This guide breaks down the earnin...
A big asset manager recently capped withdrawals from a private credit fund, shaking confidence in liquidity for inves...
Investors are watching a growing wave of AI IPO chatter. If OpenAI opts for a confidential filing, understanding the ...
A major move by a wealth manager can ripple through markets and tax strategies. Discover what truewealth exits $12.8 ...
Nvidia investors are watching a major update that could define the stock’s next phase. This guide breaks down what to...
As Micron prepares to report on June 24, investors buzz about a potential stock surge. This guide breaks down catalys...
Progressive has surged to the top of private auto insurance, outpacing rivals and growing policy counts. This deep di...